Most sold healthcare stocks in Q4 2024
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2024, measured as net reductions in reported share positions from Q3 2024 into Q4 2024. Notable reductions at the top of this list include ACADIA HEALTHCARE CO INC (ACHC), STANDARD BIOTOOLS INC (LAB), DOXIMITY INC-CLASS A (DOCS), BUTTERFLY NETWORK INC (BFLY). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ACHC | ACADIA HEALTHCARE CO INC | -6,014,326 | -$381.37M | 0 | 0 | 0 | 3 | 0 |
| LAB | STANDARD BIOTOOLS INC | -5,827,076 | -$22.40M | 0 | 0 | 1 | 1 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -4,053,743 | -$123.07M | 2 | 1 | 1 | 0 | 4 |
| BFLY | BUTTERFLY NETWORK INC | -3,755,213 | $2.82M | 0 | 0 | 2 | 0 | 2 |
| PFE | PFIZER INC | -3,622,239 | -$142.59M | 0 | 3 | 10 | 1 | 13 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -3,426,930 | $12.53M | 0 | 1 | 4 | 0 | 6 |
| ME | 23ANDME HOLDING CO -CLASS A | -3,088,861 | -$1.07M | 0 | 0 | 0 | 1 | 0 |
| QSI | QUANTUM-SI INC | -2,490,559 | $14.88M | 0 | 1 | 1 | 0 | 2 |
| NVRO | NEVRO CORP | -2,459,566 | -$14.31M | 0 | 0 | 1 | 1 | 1 |
| OPCH | OPTION CARE HEALTH INC | -2,456,670 | -$79.57M | 0 | 1 | 0 | 3 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | -2,409,663 | -$33.87M | 0 | 1 | 0 | 1 | 1 |
| CARA | CARA THERAPEUTICS INC | -2,221,974 | -$684.37K | 0 | 0 | 0 | 2 | 0 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -2,116,675 | $23.85M | 0 | 1 | 1 | 0 | 3 |
| FTRE | FORTREA HOLDINGS INC | -1,981,585 | $5.75M | 0 | 1 | 0 | 1 | 1 |
| LBPH | LONGBOARD PHARMACEUTICALS IN | -1,969,041 | -$65.63M | 0 | 0 | 0 | 1 | 0 |
| ZLAB | ZAI LAB LTD-ADR | -1,850,437 | -$44.28M | 0 | 1 | 0 | 1 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | -1,767,900 | -$1.06M | 0 | 0 | 1 | 0 | 1 |
| CNC | CENTENE CORP | -1,566,507 | -$118.07M | 0 | 0 | 1 | 2 | 1 |
| OSCR | OSCAR HEALTH INC - CLASS A | -1,529,301 | -$125.94M | 1 | 2 | 2 | 0 | 5 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -1,413,300 | -$333.53K | 0 | 0 | 1 | 0 | 1 |
| UNH | UNITEDHEALTH GROUP INC | -1,359,291 | -$1.87B | 4 | 12 | 10 | 1 | 29 |
| KZR | KEZAR LIFE SCIENCES INC | -1,297,074 | -$1.00M | 0 | 0 | 0 | 1 | 0 |
| ABT | ABBOTT LABORATORIES | -1,252,167 | -$155.80M | 0 | 2 | 3 | 0 | 10 |
| BLUE | BLUEBIRD BIO INC | -1,085,257 | -$563.79K | 0 | 0 | 0 | 2 | 0 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -1,075,441 | -$446.66M | 0 | 3 | 1 | 0 | 7 |
| EW | EDWARDS LIFESCIENCES CORP | -1,033,144 | -$60.11M | 0 | 2 | 3 | 0 | 7 |
| IMVT | IMMUNOVANT INC | -1,021,712 | -$34.69M | 0 | 0 | 2 | 0 | 2 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -932,644 | $6.21M | 0 | 0 | 1 | 0 | 2 |
| NRIX | NURIX THERAPEUTICS INC | -932,472 | -$26.51M | 0 | 0 | 1 | 1 | 1 |
| VKTX | VIKING THERAPEUTICS INC | -906,026 | -$57.36M | 0 | 0 | 0 | 2 | 0 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | -886,925 | -$16.18M | 0 | 1 | 2 | 0 | 3 |
| SNY | SANOFI-ADR | -886,331 | -$767.93M | 0 | 2 | 2 | 0 | 4 |
| ACCD | ACCOLADE INC | -882,684 | -$5.54M | 0 | 0 | 2 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | -837,884 | $112.14M | 1 | 4 | 5 | 2 | 11 |
| HLN | HALEON PLC-ADR | -827,097 | -$197.86M | 0 | 2 | 4 | 0 | 6 |
| HRTX | HERON THERAPEUTICS INC | -819,398 | -$2.18M | 0 | 0 | 1 | 0 | 1 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -800,751 | -$167.73M | 1 | 5 | 1 | 1 | 7 |
| MOH | MOLINA HEALTHCARE INC | -756,669 | -$313.51M | 0 | 1 | 3 | 0 | 4 |
| GLYC | GLYCOMIMETICS INC | -739,947 | -$121.76K | 0 | 0 | 1 | 0 | 1 |
| VCYT | VERACYTE INC | -710,394 | $2.53M | 0 | 1 | 1 | 0 | 2 |
| OGN | ORGANON & CO | -695,188 | -$40.87M | 0 | 0 | 3 | 1 | 3 |
| CAH | CARDINAL HEALTH INC | -670,614 | -$60.57M | 0 | 2 | 1 | 2 | 4 |
| NVAX | NOVAVAX INC | -657,253 | -$14.76M | 0 | 0 | 1 | 0 | 1 |
| ALHC | ALIGNMENT HEALTHCARE INC | -655,718 | -$11.37M | 0 | 1 | 1 | 0 | 2 |
| BAYRY | BAYER AG-SPONSORED ADR | -653,317 | -$21.71M | 0 | 0 | 1 | 0 | 1 |
| CHRS | COHERUS BIOSCIENCES INC | -631,630 | -$464.20K | 0 | 0 | 1 | 1 | 1 |
| PSTX | POSEIDA THERAPEUTICS INC | -626,403 | $36.38K | 0 | 0 | 1 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | -615,980 | -$7.12M | 0 | 0 | 2 | 0 | 2 |
| CRBU | CARIBOU BIOSCIENCES INC | -594,200 | -$1.16M | 0 | 0 | 0 | 1 | 0 |
| ATYR | ATYR PHARMA INC | -574,720 | $56.98K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2024
What are the most sold Healthcare stocks in Q4 2024?
The most sold healthcare stocks in Q4 2024 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q3 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2024?
Among the managers we track, net reductions were largest in companies such as ACADIA HEALTHCARE CO INC (ACHC), STANDARD BIOTOOLS INC (LAB), DOXIMITY INC-CLASS A (DOCS), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2024).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.